[1]张子然,李柯然.角膜淋巴管生成的内源性调控因素及新生淋巴管相关眼表疾病研究进展[J].眼科新进展,2024,44(3):239-243.[doi:10.13389/j.cnki.rao.2024.0047]
　ZHANG Ziran,LI Keran.Research progress in the endogenous regulatory factors of corneal lymphangiogenesis and its related ocular surface diseases[J].Recent Advances in Ophthalmology,2024,44(3):239-243.[doi:10.13389/j.cnki.rao.2024.0047]
点击复制

角膜淋巴管生成的内源性调控因素及新生淋巴管相关眼表疾病研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
44卷
期数:
2024年3期
页码:
239-243
栏目:
文献综述
出版日期:
2024-03-05

文章信息/Info

Title:
Research progress in the endogenous regulatory factors of corneal lymphangiogenesis and its related ocular surface diseases
作者:
张子然; 李柯然
211166　江苏省南京市，南京医科大学（张子然，李柯然）；210029　江苏省南京市，南京医科大学眼科医院（李柯然）
Author(s):
ZHANG Ziran1; LI Keran1; 2
1.Nanjing Medical University,Nanjing 211166,Jiangsu Province,China
2.The Affiliated Eye Hospital of Nanjing Medical University,Nanjing 210029,Jiangsu Province,China
关键词:
角膜; 角膜新生淋巴管; 内源性调控因素; 眼表疾病
Keywords:
cornea;  corneal lymphangiogenesis;  endogenous regulatory factors;  ocular surface diseases
分类号:
R772.2
DOI:
10.13389/j.cnki.rao.2024.0047
文献标志码:
A
摘要:
正常角膜无血管和淋巴管。角膜感染、化学烧伤、移植排斥反应等病理性刺激可破坏促淋巴管生成因素与抗淋巴管生成因素间的平衡，致使淋巴管从角膜缘向角膜中央延伸。角膜新生淋巴管的形成与多种调控因素及细胞信号通路密切相关，深入研究并阐明角膜淋巴管生成的机制将为角膜移植排斥反应、炎症性疾病、干眼症和肿瘤转移等相关领域的研究开辟新的方向。本文综述了角膜淋巴管生成的内源性调控因素及新生淋巴管相关眼表疾病的治疗策略。
Abstract:
Blood and lymphatic vessels are absent from the normal cornea. Pathological stimulation such as corneal infection, chemical burns and transplantation rejection can disrupt the balance between pro- and anti-lymphangiogenesis factors, causing lymphatic vessels to extend from the corneal limbus to the central cornea. Corneal lymphangiogenesis is closely related to various regulatory factors and cellular signaling pathways. Further study and elucidation of the mechanism of corneal lymphangiogenesis will open up new directions for treating corneal transplantation rejection, inflammatory diseases, dry eyes and tumor metastasis. This review concludes the endogenous regulatory factors of corneal lymphangiogenesis and therapeutic strategies for its related ocular surface diseases.

参考文献/References:

［1］　ROSHANDEL D,ESLANI M,BARADARAN-RAFII A,CHEUNG A Y,KURJI K,JABBEHDARI S,et al.Current and emerging therapies for corneal neovascularization［J］.Ocul Surf,2018,16(4):398-414.
［2］　NARIMATSU A,HATTORI T,KOIKE N,TAJIMA K,NAKAGAWA H,YAMAKAWA N,et al.Corneal lymphangiogenesis ameliorates corneal inflammation and edema in late stage of bacterial keratitis［J］.Sci Rep,2019,9(1):2984.
［3］　GUCCIARDO E,LOUKOVAARA S,SALVEN P,LEHTI K.Lymphatic vascular structures:a new aspect in proliferative diabetic retinopathy［J］.Int J Mol Sci,2018,19(12):4034.
［4］　MELINCOVICI C S,BO?CA A B,?U?MAN S,M?RGINEAN M,MIHU C,ISTRATE M,et al.Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis［J］.Rom J Morphol Embryol,2018,59(2):455-467.
［5］　BJ?RNDAHL M A,CAO R,BURTON J B,BRAKENHIELM E,RELIGA P,GALTER D,et al.Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis［J］.Cancer Res,2005,65(20):9261-9268.
［6］　DELLINGER M T,MEADOWS S M,WYNNE K,CLEAVER O,BREKKEN R A.Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature［J］.PLoS One,2013,8(9):e74686.
［7］　SECKER G A,HARVEY N L.Regulation of VEGFR signalling in lymphatic vascular development and disease:an update［J］.Int J Mol Sci,2021,22(14):7760.
［8］　HOLASH J,DAVIS S,PAPADOPOULOS N,CROLL S D,HO L,RUSSELL M,et al.VEGF-Trap:a VEGF blocker with potent antitumor effects［J］.Proc Natl Acad Sci USA,2002,99(17):11393-11398.
［9］　S?INZ-JASPEADO M,CLAESSON-WELSH L.Cytokines regulating lymphangiogenesis［J］.Curr Opin Immunol,2018,53:58-63.
［10］　LE V N H,HOS D,HOU Y,WITT M,BARKOVSKIY M,BOCK F,et al.VEGF TrapR1R2 suspended in the semifluorinated alkane f6h8 inhibits inflammatory corneal hem- and lymphangiogenesis［J］.Transl Vis Sci Technol,2020,9(11):15.
［11］　ZHANG W,SCH?NBERG A,BOCK F,CURSIEFEN C.Posttransplant VEGFR1R2 trap eye drops inhibit corneal(lymph)angiogenesis and improve corneal allograft survival in eyes at high risk of rejection［J］.Transl Vis Sci Technol,2022,11(5):6.
［12］　ZHANG W,SCHNBERG A,HAMDORF M,GEORGIEV T,CURSIEFEN C,BOCK F.Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival［J］.Br J Ophthalmol,2022,106(11):1617-1626.
［13］　SAHARINEN P,EKLUND L,ALITALO K.Therapeutic targeting of the angiopoietin-TIE pathway［J］.Nat Rev Drug Discov,2017,16(9):635-661.
［14］　COLLAZOS-ALEM?N J D,GNECCO-GONZ?LEZ S,JARAMILLO-ZARAMA B,JIM?NEZ-MORA M A,MENDIVIL C O.The role of angiopoietins in neovascular diabetes-related retinal diseases［J］.Diabetes Ther,2022,13(11-12):1811-1821.
［15］　高倩倩,吕仁荣,徐广琪,毕见海,霍然,肖虎.Ang/Tie2通路在肿瘤血管生成中作用的研究进展［J］.组织工程与重建外科,2021,17(2):159-164.
GAO Q Q,L R R,XU G Q,BI J H,HUO R,XIAO H.Research progress on the role of angiopoietin-tie2 pathway in tumor angiogenesis［J］.J Tissue Eng Reconstr Surg,2021,17(2):159-164.
［16］　GALE N W,THURSTON G,HACKETT S F,RENARD R,WANG Q,MCCLAIN J,et al.angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning,and only the latter role is rescued by angiopoietin-1［J］.Dev Cell,2002,3(3):411-423.
［17］　TOYONO T,USUI T,YOKOO S,KIMAKURA M,NAKAGAWA S,YAMAGAMI S,et al.Angiopoietin-like protein 2 is a potent hemangiogenic and lymphangiogenic factor in corneal inflammation［J］.Invest Ophthalmol Vis Sci,2013,54(6):4278.
［18］　ZHENG W,NURMI H,APPAK S,SABINE A,BOVAY E,KORHONEN E A,et al.Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions［J］.Genes Dev,2014,28(14):1592-1603.
［19］　ZHANG L,LI G,SESSA R,KANG G J,SHI M,GE S,et al.Angiopoietin-2 blockade promotes survival of corneal transplants［J］.Invest Ophthalmol Vis Sci,2017,58(1):79.
［20］　WANG H,YANG J,ZHANG K,LIU J,LI Y,SU W,et al.Advances of fibroblast growth factor/receptor signaling pathway in hepatocellular carcinoma and its pharmacotherapeutic targets［J］.Front Pharmacol,2021,12:650388.
［21］　DAILEY L,AMBROSETTI D,MANSUKHANI A,BASILICO C.Mechanisms underlying differential responses to FGF signaling［J］.Cytokine Growth Factor Rev,2005,16(2):233-247.
［22］　CAO R,JI H,FENG N,ZHANG Y,YANG X,ANDERSSON P,et al.Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis［J］.Proc Natl Acad Sci USA,2012,109(39):15894-15899.
［23］　XIE F,ZHANG X,LUO W,GE H,SUN D,LIU P.Notch signaling pathway is involved in BFGF-induced corneal lymphangiogenesis and hemangiogenesis［J］.J Ophthalmol,2019,2019:1-13.
［24］　GURUNG H R,CARR M M,BRYANT K,CHUCAIR-ELLIOTT A J,CARR D J.Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection［J］.Mucosal Immunol,2018,11(1):172-185.
［25］　麦洁英,唐先玲,刘平.新生淋巴管与角膜移植排斥的研究进展［J］.国际眼科杂志,2014,14(12):2168-2171.
MAI J Y,TANG X L,LIU P.Research advances in corneal newborn lymphatic vessel and corneal transplantation rejection［J］.Int Eye Sci,2014,14(12):2168-2171
［26］　MAIER A K B,REICHHART N,GONNERMANN J,KOCIOK N,RIECHARDT A I,GUNDLACH E,et al.Effects of TNFα receptor TNF-Rp55- or TNF-Rp75- deficiency on corneal neovascularization and lymphangiogenesis in the mouse［J］.PLoS One,2021,16(4):e0245143.
［27］　ZHANG Q,LU Y,PROULX S T,GUO R,YAO Z,SCHWARZ E M,et al.Increased lymph angiogenesis in joints of mice with inflammatory arthritis［J］.Arthritis Res Ther,2007,9(6):R118.
［28］　FERRARI G,BIGNAMI F,GIACOMINI C,FRANCHINI S,RAMA P.Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring［J］.Invest Ophthalmol Vis Sci,2013,54(3):1680.
［29］　CHOI I,LEE Y S,CHUNG H K,CHOI D,ECOIFFIER T,LEE H N,et al.Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration［J］.Angiogenesis,2013,16(1):29-44.
［30］　HAN L,ZHANG M,LIANG X,JIA X,JIA J,ZHAO M,et al.Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway［J］.Sci Rep,2017,7(1):10602.
［31］　LEE S J,IM S T,WU J,CHO C S,JO D H,CHEN Y,et al.Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3［J］.Ocul Surf,2021,22:72-79.
［32］　ZHANG Y,ZHANG C,LI L,LIANG X,CHENG P,LI Q,et al.Lymphangiogenesis in renal fibrosis arises from macrophages via VEGF-C/VEGFR3-dependent autophagy and polarization［J］.Cell Death Dis,2021,12(1):109.
［33］　ABDELFATTAH N S,AMGAD M,ZAYED A A.Host immune cellular reactions in corneal neovascularization［J］.Int J Ophthalmol,2016,9(4):625-633.
［34］　HADRIAN K,WILLENBORG S,BOCK F,CURSIEFEN C,EMING S A,HOS D.Macrophage-mediated tissue vascularization:similarities and differences between cornea and skin［J］.Front Immunol,2021,12:667830.
［35］　HOS D,BUCHER F,REGENFUSS B,DREISOW M L,BOCK F,HEINDL L M,et al.IL-10 Indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages［J］.Am J Pathol,2016,186(1):159-171.
［36］　GONZ?LEZ-DE-OLANO D,?LVAREZ-TWOSE I.Mast cells as key players in allergy and inflammation［J］.J Investig Allergol Clin Immunol,2018,28(6):365-378.
［37］　LIU J,LI Z.Resident innate immune cells in the cornea［J］.Front Immunol,2021,12:620284.
［38］　CHO W,MITTAL S K,ELBASIONY E,CHAUHAN S K.Activation of ocular surface mast cells promotes corneal neovascularization［J］.Ocul Surf,2020,18(4):857-864.
［39］　CHO W,MITTAL S K,ELBASIONY E,CHAUHAN S K.Ocular surface mast cells promote inflammatory lymphangiogenesis［J］.Microvasc Res,2022,141:104320.
［40］　CLAHSEN T,HADRIAN K,NOTARA M,SCHLERETH S L,HOWALDT A,PROKOSCH V,et al.The novel role of lymphatic vessels in the pathogenesis of ocular diseases［J］.Prog Retin Eye Res,2023,96:101157.
［41］　ZHONG W,MONTANA M,SANTOSA S M,ISJWARA I D,HUANG Y H,HAN K Y,et al.Angiogenesis and lymphangiogenesis in corneal transplantation-A review［J］.Surv Ophthalmol,2018,63(4):453-479.
［42］　SINGH N,TIEM M,WATKINS R,CHO Y K,WANG Y,OLSEN T,et al.Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity［J］.Blood,2013,121(20):4242-4249.
［43］　HUANG Y,LU M,WANG Y,ZHANG C,CAO Y,ZHANG X.Podoplanin:a potential therapeutic target for thrombotic diseases［J］.Front Neurol,2023,14:1118843.
［44］　MARUYAMA Y,MARUYAMA K,KATO Y,KAJIYA K,MORITOH S,YAMAMOTO K,et al.The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions［J］.Invest Ophthalmol Vis Sci,2014,55(8):4813.
［45］　LE V N H,SCHNEIDER A C,SCHOLZ R,BOCK F,CURSIEFEN C.Fine needle-diathermy regresses pathological corneal (lymph)angiogenesis and promotes high-risk corneal transplant survival［J］.Sci Rep,2018,8(1):5707.
［46］　HOU Y,LE V N H,TTH G,SIEBELMANN S,HORSTMANN J,GABRIEL T,et al.UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high- risk corneal transplant survival［J］.Am J Transplant,2018,18(12):2873-2884.
［47］　唐颖,田甜,葛红岩.干眼症发病机制与发病因素的研究进展［J］.医学综述,2019,25(11):2196-2201.
TANG Y,TIAN T,GE H Y.Research development of pathogenesis and influence factors in xerophthalmia［J］.Med Recapitul,2019,25(11):2196-2201
［48］　JI Y W,LEE J L,KANG H G,GU N,BYUN H,YEO A,et al.Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease［J］.Ocul Surf,2018,16(3):306-313.
［49］　KASETSUWAN N,CHANTARALAWAN K,REINPRAYOON U,UTHAITHAMMARAT L.Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease:A double-masked,randomized trial［J］.PLoS One,2020,15(6):e0234186.
［50］　赵壮红,晏聃,周代娇,张慧.淋巴管形成与单纯疱疹病毒性角膜炎的关系［J］.眼科新进展,2018,38(10):990-994.
ZHAO Z H,YAN D,ZHOU D J,ZHANG H.The relationship between lymphangiogenesis and herpes simplex keratitis［J］.Rec Adv Ophthalmol,2018,38(10):990-994
［51］　康慧颖,曹启江,张朔,海洋.单纯疱疹病毒性角膜炎治疗方法研究进展［J］.传染病信息,2021,34(4):365-369.
KANG H Y,CAO Q J,ZHANG S,HAI Y.Research progress in herpes simplex keratitis treatment［J］.Infect Dis Inform,2021,34(4):365-369.
［52］　FOULSHAM W,DOHLMAN T H,MITTAL S K,TAKETANI Y,SINGH R B,MASLI S,et al.Thrombospondin-1 in ocular surface health and disease［J］.Ocul Surf,2019,17(3):374-383.
［53］　WUEST T R,CARR D J J.VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis［J］.J Exp Med,2010,207(1):101-115.
［54］　PATNAM M,DOMMARAJU S R,MASOOD F,HERBST P,CHANG J H,HU W Y,et al.Lymphangiogenesis guidance mechanisms and therapeutic implications in pathological states of the cornea［J］.Cells,2023,12(2):319.

相似文献/References:

[1]王存 薛芸霞 杨亚兵 傅婷 李志杰 夏潮涌.小鼠出生前后角膜神经分布的变化[J].眼科新进展,2012,32(6):000.
[2]李雪 赵延军 张丽 胡琦 王珂萌.近视眼患者LASIK和LASEK术后角膜后表面变化的比较研究[J].眼科新进展,2012,32(6):000.
[3]赵伟 周瑾 郭梦翔 项道满.地塞米松对碱烧伤后大鼠角膜核转录因子-κB活化的影响[J].眼科新进展,2013,33(7):000.
[4]张研 陆晓和.角膜血管新生机制与调控新进展[J].眼科新进展,2008,28(9):000.
[5]王茜 吴良成 李铭.准分子激光角膜屈光手术后非球面系数的影响因素[J].眼科新进展,2012,32(4):000.
[6]付馨余 邹文进 黄明汉 赵静博.多西环素对碱烧伤大鼠角膜组织中NF-κB和bcl-2表达的影响[J].眼科新进展,2013,33(4):000.
[7]闵捷 胡丹 孙丽娟 雷润佳 王鹤霏 蔡莉.紫外光核黄素胶原交联对兔角膜碱烧伤作用的实验研究[J].眼科新进展,2013,33(5):000.
[8]白华 黄一飞.Boston型人工角膜的临床并发症及其处理[J].眼科新进展,2013,33(9):000.
[9]唐敏 席兴华 唐罗生 岳丽菁.人羊膜匀浆提取液对兔角膜成纤维细胞增殖和TGF-β1mRNA表达的影响[J].眼科新进展,2013,33(11):000.
[10]李海中 彭清华 王芬 姚小磊 李文娟.密蒙花总黄酮对去势雄鼠角膜组织Fas、FasL表达的影[J].眼科新进展,2013,33(12):000.

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：82171080）
更新日期/Last Update: 2024-03-05